JW Pharmaceutical Corp (001065) — Cash Flow Reinvestment Rate
JW Pharmaceutical Corp (001065) has a Cash Flow Reinvestment Rate of 0.44x as of September 2025, reinvesting ₩20.68 Billion (capex ₩9.80 Billion plus investments ₩10.88 Billion) from operating cash flow of ₩46.92 Billion. Explore JW Pharmaceutical Corp capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
JW Pharmaceutical Corp Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for JW Pharmaceutical Corp across 10 annual periods. Also explore JW Pharmaceutical Corp assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for JW Pharmaceutical Corp (2014–2024)
Year-by-year capital reinvestment analysis for JW Pharmaceutical Corp. For live market cap and broader valuation context, see 001065 market cap.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.75x | ₩59.86 Billion | ₩79.39 Billion | ₩28.14 Billion | ▼ -37.1% |
| 2023 | 1.20x | ₩104.49 Billion | ₩87.16 Billion | ₩40.71 Billion | ▲ +87.7% |
| 2022 | 0.64x | ₩36.26 Billion | ₩56.76 Billion | ₩9.92 Billion | ▲ +35.5% |
| 2021 | 0.47x | ₩8.55 Billion | ₩18.12 Billion | ₩7.47 Billion | ▼ -60.0% |
| 2020 | 1.18x | ₩74.34 Billion | ₩63.05 Billion | ₩12.39 Billion | ▲ +529.0% |
| 2019 | 0.19x | ₩10.41 Billion | ₩55.53 Billion | ₩9.28 Billion | ▼ -29.3% |
| 2018 | 0.27x | ₩13.82 Billion | ₩52.11 Billion | ₩8.64 Billion | ▲ +17.9% |
| 2017 | 0.22x | ₩7.52 Billion | ₩33.45 Billion | ₩7.50 Billion | ▼ -91.9% |
| 2016 | 2.79x | ₩18.79 Billion | ₩6.74 Billion | ₩10.02 Billion | ▲ +131.2% |
| 2014 | 1.21x | ₩8.78 Billion | ₩7.28 Billion | ₩6.93 Billion | — |